Appetite For Korean Biotechs Turns Sour, Voronoi Withdraws IPO

Bioventure Floats Drop In 1Q

disappointment
Korea Exchange Increasingly Turns Down Bioventure IPO Approvals • Source: Alamy

More from South Korea

More from Focus On Asia